Avantor Inc (AVTR)
21.04
-0.11
(-0.52%)
USD |
NYSE |
Nov 15, 09:34
Avantor Cash from Investing (Quarterly): -40.50M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -40.50M |
June 30, 2024 | -44.90M |
March 31, 2024 | -34.20M |
December 31, 2023 | -50.00M |
September 30, 2023 | -37.00M |
June 30, 2023 | -29.40M |
March 31, 2023 | -27.30M |
December 31, 2022 | -33.10M |
September 30, 2022 | 4.10M |
June 30, 2022 | -41.10M |
March 31, 2022 | -39.50M |
December 31, 2021 | -2.884B |
September 30, 2021 | -34.30M |
June 30, 2021 | -1.189B |
Date | Value |
---|---|
March 31, 2021 | -14.60M |
December 31, 2020 | -18.80M |
September 30, 2020 | -15.90M |
June 30, 2020 | -12.50M |
March 31, 2020 | -11.90M |
December 31, 2019 | -11.40M |
September 30, 2019 | -10.40M |
June 30, 2019 | -12.40M |
March 31, 2019 | -7.90M |
December 31, 2018 | 0.00 |
September 30, 2018 | -4.20M |
June 30, 2018 | -7.20M |
March 31, 2018 | -11.80M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.884B
Minimum
Dec 2021
4.10M
Maximum
Sep 2022
-228.26M
Average
-33.65M
Median
Cash from Investing (Quarterly) Benchmarks
Revvity Inc | 690.18M |
Bruker Corp | -67.60M |
Azenta Inc | 201.62M |
Harvard Bioscience Inc | -1.111M |
Bionano Genomics Inc | 28.63M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 244.80M |
Cash from Financing (Quarterly) | -198.60M |
Free Cash Flow | 747.20M |
Free Cash Flow Per Share (Quarterly) | 0.2987 |
Free Cash Flow to Equity (Quarterly) | 397.90M |
Free Cash Flow to Firm (Quarterly) | 241.78M |
Free Cash Flow Yield | 5.21% |